AI-generated summary
The authors report a randomized, single-blind controlled trial of photobiomodulation in 80 people with congenital red-green color vision deficiency. Color recognition improved more in the treatment group than in controls across several measures, with larger gains reported in green deficiency. The abstract does not give wavelengths or report the effect size.
- Participants
- 80
- Who or what was studied
- Individuals diagnosed with congenital red-green color vision deficiency
- Limits stated in the abstract
- The abstract does not report wavelengths, dosing, effect sizes, or follow-up beyond 4 weeks.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Congenital color vision deficiency (CVD) is a prevalent ophthalmic condition for which effective therapeutic interventions remain limited. This study evaluated the efficacy of photobiomodulation (PBM) therapy in individuals with congenital CVD.
Methods
A randomized, single-blind, controlled clinical trial was conducted involving 80 participants diagnosed with red-green CVD. Participants were randomly assigned to either a PBM treatment group or a control group. Color vision performance was assessed at baseline, and after 1, 2, and 4 weeks of intervention. Statistical analyses were conducted using the Kruskal-Wallis test with Dunn's post hoc test for multiple comparisons.
Results
Color vision recognition ability demonstrated a statistically significant improvement in the PBM treatment group compared to the control group across various parameters (p < 0.05).
Conclusion
Non-invasive PBM therapy significantly enhances color vision in individuals with congenital CVD, with particularly notable improvements observed in those with green CVD.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.